From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Taryne A. Imai, MD, found herself at a professional crossroads in 2022. She had been working for seven years as a thoracic surgeon, most recently as Clinical Chief of Thoracic Surgery at Cedars-Sinai ...

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10, 2026 ...

HonorHealth is first in the nation to use new handheld robotic technology for joint replacement, bringing greater ...

By Constance GbedzoThe economic trajectory of Ghana in 2026 stands as a powerful testament to the superiority of asset-backed sovereignty over the fragile, debt-laden strategies of the period ...

Dr. David Mahjoubi, MD, a board-certified anesthesiologist with over 17 years of experience in ketamine administration, has launched NutraBrain Clinic, a telehealth platform offering ...

Harrow Inc (HROW) reports a robust 33% revenue growth in Q4 2025, with strategic plans to expand market share and product offerings in 2026.

Dr. Ganni Bhaskara Rao’s journey proves that world-class healthcare is not the prerogative of the metropolis alone. By ...

Officials with the FDA have approvedthe first generic robenacoxib injectable (Robenacoxib Injection; Cronus Pharma Specialties) for the control of postoperative pain and inflammation in canine and ...

Everyone deserves access to safe, affordable health care. As elected officials and health care professionals, one of our top priorities is ensuring New Hampshire’s citizens have access to quality care ...

In total, 314 employees with 20 or more years of service will be honored by the university during a come-and-go reception from 3-4:30 p.m. March 30, 2026, in the Hill Student Center Ballrooms.

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10, 2026 ...